Long-term outcome of early versus delaye
β
Robert A. Hauser; Mark F. Lew; Howard I. Hurtig; William G. Ondo; Joanne Wojcies
π
Article
π
2009
π
John Wiley and Sons
π
English
β 329 KB
π 1 views
## Abstract The purpose of this study to compare the longβterm clinical outcome of early versus delayed rasagiline treatment in early Parkinson's disease (PD). Subjects (N = 404) were randomly assigned to initial treatment with rasagiline (earlyβstart group) or placebo for 6 months followed by rasa